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ABSTRACT: Central Neuropathic Pain (CNP) is a 
frequent chronic condition in people with spinal cord 
injury (SCI). In a previous study, we showed that using 
laboratory brain-computer interface (BCI) technology for 
neurofeedback training, it is possible to reduce pain in 
SCI people who suffered from CNP for many years.  In 
this study, we show initial results from 12 people with 
SCI and CNP who practiced neurofeedback on their own 
using our portable BCI, consisting of a wearable EEG 
headset (Emotiv, EPOC, USA) and a computer 
tablet. Eight participants showed a positive initial 
response to neurofeedback and seven learned how to use 
portable BCI on their own at home. In this paper, we 
present a portable BCI and discuss the main challenges 
of training lay people, patients and their caregivers, to 
use a custom designed BCI application at home. 
 
INTRODUCTION 
 
Brain-computer Interface has been a focus 
of multidisciplinary research for almost two decades, and 
most of its applications have been designed for patients. 
Yet with the exception of  BCI spellers for nearly locked 
in people [1] and brain painting BCI [2], there is no 
reported application of BCI that patients can use at home 
on their own, though several studies explored priorities 
of potential BCI home users, including patients with SCI 
[3] . There are several consumer 
BCI systems in the research phase or on the market [4], 
but their applications are mainly for gaming 
or improving the concentration of the able-bodied 
population. Furthermore, consumer BCI applications 
typically do not involve EEG recording during training 
allowing post hoc analysis, so it is hard to check user’s 
actual performance. 
It is reasonable to assume that the main users of 
consumer BCI systems are people who like technical 
innovations [4]. The experience of these people might 
not necessarily be directly transferable to patients who 
may have a physical or cognitive disability, belong to an 
older age group and possibly do not share a passion for 
technical innovations. 
With the advent of portable and inexpensive 
EEG [4], it became possible to organize feasibility 
pragmatic studies, on a larger number of participants to 
observe how lay people, with mild to severe physical 
impairments and with average consumer technical 
literacy use BCI on their own. Due to the nature of 
participants, it is equally important  to understand the 
attitude of their caregivers towards an unconventional 
assistive/rehabilitation device.  
In this paper, we present, to the best of our knowledge, 
the first pragmatic (not directly controlled by a 
researcher) feasibility study of neurofeedback treatment 
of SCI patients based on [5], using BCI technology 
in a home environment. We present the main 
components of custom-made software for portable BCI 
and the effect of training on pain. The main focus of the 
paper is however patients’ experience of using the BCI 
system on their own.  
 
MATERIALS AND METHODS 
 
Patients: Twelve patients (54±9, 2F) with chronic 
SCI and with previously diagnosed CNP were included 
in the study (Table 1).  Paraplegic and tetraplegic adult 
patients, with complete or incomplete injury, were 
included in the study. Americal Spinal Injury 
Association (ASIA) impairment scale level A-D 
corresponds to the different levels of severity of motor 
and sensory impairments [6]. The level of injury C 
(cervical) correspond to tetraplegia while T (thoracic) 
and L (lumbar) to paraplegia (Table 1).  
Exclusion criteria were the patients’ inability to 
understand the task, epilepsy or any self-reported mental 
health problem. Minimum computer literacy and 
Internet access were required. Patients were asked to try 
not to change their regular pain medications (pregabalin 
or amitryptiline) throughout the study as this could   
influence the outcome. Only patients with CNP equal to 
or greater than 4 on the Visual Numerical Scale VNS 
(0=no pain, 10=worst pain imaginable) were included in 
the study. All patients signed the informed consent. 
Ethical permission was obtained from the local 
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national healthcare service Ethical Committee.  
BCI software: Custom-made software was created in 
visual C++.net. It consisted of three main parts: raw EEG 
data collected through a wireless communication with 
the headset, signal processing following the algorithm 
described in [5], and a graphical user interface. The 
graphical user interface had three screens (Fig.1). It 
consisted of the main screen for neurofeedback training, 
pain diary screen and screen for setting system 
parameres. Control buttons on the main screen were 
color coded to enable persons with mild vision problems 
to easily recognize different commands. 
Electronic pain diary (in VNS units) had to be filled out 
before the start of training and before logging off. EEG 
signal was recorded during training and the experimenter 
could remotely access patients’ EEG to upload the data if 
patients allowed  access.  
     Neurofeedback training: Prior to taking portable BCI 
home for neurofeedback training, patients had up to four 
30 min long neurofeedback pre-training sessions 
using a laboratory device usbamp (Guger Technologies, 
Austria) following protocol [5]. The EEG sampling 
frequency was 256 samples/s, the right ear served as a 
reference and the left ear as a ground. The impedance 
 was set prior to the EEG recording to a value under          
5kΩ.  At the very beginning, a 2 min  EEG was recorded 
to serve as a baseline for subsequent neurofeedback. 
Training was provided from C4, located over the primary 
motor cortex, which is an area typically targeted by 
neuromodulatory treatments of CNP [7]. Patients were 
presented with a graphical user interface (GUI) showing 
three bars. The bars changed size and color, to either red 
or green (Fig .2). Patients were instructed to “do 
whatever necessary to make bars green”. Three bars 
represented the theta, alpha and higher beta (20-30 Hz) 
band relative power. Relative power was calculated as a 
power of a chosen frequency band divided by a power in 
2-30 Hz band. The bars representing theta and beta 
band had a green color when the relative power was 10% 
or more, below the baseline value, otherwise, they 
had a red color. A bar representing the alpha band had a 
green color when the power was 10% or more, above the 
baseline value, otherwise was red. Chosen features were 
based on our study defining markers of CNP [8]. Four 
sessions for the initial assessment of the effect of 
neurofeedback on pain were chosen based on 
the literature [9]. A subset of patients, who 
reported a reduction in pain of at least a 1 grade on 
the VNS and in addition reported sensations such as 
tingling or pleasant heat during neurofeedback pre-
training, were included in the 2nd part of the study, using 
BCI at home.  In the previous study [5] it was noticed that 
these sensations often precede the reduction of pain. 
Because patients were not informed about these 
sensations prior to training, this served as a quick “anti-
placebo” test.      
Questionnaires and Communication with Patients:  
Upon arrival at the laboratory, the purpose of the study 
was explained to patients. A semi-structured interview 
was either audio recorded or notes were taken by two 
experimenters. After briefly demonstrating how the BCI 
system works, on the first session, they were asked to 
complete a custom-made questionnaire on the 
“Perceived usefulness of a device for a home-based 
treatment of central neuropathic pain”, a validated 
questionnaires “Brief Pain Inventory” [10] and 
“Neuropathic pain symptoms inventory” [11]. Patients 
were contacted after one week and after one month 
by either phone, SMS, email or Skype, and some visited 
the laboratory. Volunteers who completed the study have 
been asked to finally complete the “Brief 
Pain  Inventory” and a custom-made questionnaire: 
“Neuropathic system users questionnaire”. 
 
Educating patients to use portable BCI: on each 
session, following neurofeedback pre-training with 
usbamp, patients and their caregivers were trained to 
use the EPOC headset and a custom made software. 
Tuition consisted of three parts: training to adequately 
moisten the electrodes and to place the headset on the 
right location of the head, training to use Emotiv 
proprietary software to check the electrode-skin 
impedance and training to use a custom designed BCI 
software. The headset was tilted back compared to the 
recommended use by Emotiv, so that the electrode 
locations F3 and F4 were located approximately at 
locations C3 and C4 (or for smaller heads between C3 
and C1 and between C4 and C2). To find the right 
location, patients were instructed to imagine a vertical 
line coming from their ears and to place the device in 
such a way that one long EEG electrode is placed just to 
the front of that line and the other long electrode just 
to the back, as shown in Fig. 2.  The electrode just behind 
the vertical red line was used for neurofeedback 
training. A photo of a patient wearing the headset 
 was also taken on the patient’s smartphone.  
Following this, patients were taught how to use a GUI to 
check the color-coded electrode impedance (Emotiv 
proprietary software). They were instructed to add saline 
and press the electrodes gently, aiming for the green 
colour to appear on all electrodes. The electrode from 
which neurofeedback training was provided was labeled 
with a sticker so that patients could be sure that it always 
had good contact. In order to assure a good tight contact 
between a headset and the head, in particular, a good 
contact of the reference electrodes, patients were given 
an elastic band to wrap around the head to prevent the 
headset from slipping. EPOC EEG has a sampling 
frequency of 128 samples/s and two references at P3 and 
P4 (in the case of this application they were placed over 
parietal lobes close to ears) for CMS/DRL noise 
cancellation. As the last step, patients and caregivers 
were trained to use the custom-made software. Before 
they got a portable BCI to take home, they had to 
demonstrate to the experimenter that they were capable 
of doing all three steps on their own (placing EEG 
headset, impedance check, neurofeedback training). Two 
manuals were provided to patients: a 
proprietary EPOC headset manual and a custom-made 
manual explaining how to correctly place the headset 
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for the purpose of neurofeedback training and how to 
use the custom-made software. Patients were offered as 
many sessions as needed to learn to use the portable BCI. 
Neurofeedback protocol with portable BCI followed 
the same rules as the one with ‘usbamp‘, previously 
described. They were asked to use BCI for three months, 
at least once a week and were offered to keep it following 
that period. 
 
  
Figure 1. Main screens. Upper: Pain diary; Middle: 
Neurofeedback GUI; Lower: System parameteres 
 
 
 
 
RESULTS 
 
Information about patients is provided in Table. 1, 
while information about training is provided in 
Table. 2. In Table. 2, the first column to the left shows 
the intensity of pain as measured by VNS for each patient 
before and after the first few assessment sessions. 
Column ‘Min pain’ is the minimum intensity of pain 
reported while using BCI at home. Column “Nr AS” 
shows the number of assessment/education 
sessions, column  “Nr SS” shows the number of 
additional support sessions requested by a patient, after 
starting to use BCI at home. These sessions were in 
addition to regular checks-ups after a week and a month. 
Column “Diff” shows the patient’ perceived difficulty of 
using a portable BCI (1=very easy, 10=extremely 
difficult), the average value shown in 
Table. 3. Finally, the last column shows how long 
patients used the system for. The only person who 
considered BCI difficult to use (Diff=7) gave up after 
trying to use it for a month. 
Fig. 3 shows one example of EEG Power Spectrum 
Density (PSD) taken from a home based neurofeedback 
session of one representative patient. The blue colour 
represents PSD during 2 min long EEG baseline 
recording while the red color represents PSD during 
5min long neurofeedback sub-session.  The patient was 
successfully reducing theta and higher beta power and to 
a lesser degree was increasing the power of the alpha 
band. This example shows that patients can successfully 
use the system on their own and that they are capable of 
simultaneously increasing and decreasing EEG power in 
different frequency bands. 
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Patient demographic. Seven patients were paraplegic 
and five were tetraplegic. Three tetraplegic patients had 
an injury that prevented them from using their hands, so 
they required a caregiver to help them with using the 
headset. One of them gave up after the first session, due 
to ill health, one patient and a caregiver were interested 
in using BCI but the patient had no response to 
neurofeedback and one patient had a supportive caregiver 
and a response to neurofeedback.  
Table 1. Information about patients 
 Age/gender/ 
 
Injury 
level 
       ASIA Years 
since injury 
P1.    62 M L3/L4 D 9 
P2.    51 M T6/T7 D 7 
P3.    56 F T5 D 3 
P4.    64 M T4 A 7 
P5.    66 M L3 D 5 
P6     59 M C2 B 5 
P7.    59 M C2 A 7 
P8.    50 M C3/C5 D 3 
P9.    54 F T5 A 7 
P10.  35 M C4 D 15 
P11.  42 M C2 A 1 
P12.  49 M T6 B 1 
 
Table 2. Information about pain level and the number of  
support sessions. Nr AS: the number of assessment and 
training sessions, Nr SS: number of additional support 
sessions. Diff: estimated difficulty of using portable BCI. 
Pain before/ 
after initial 
assessment  
Min 
pain  
Nr  
AS  
Nr  
SS 
 Diff Home use 
(months) 
P1.    10/8 1 2 / 2           10 
P2.    7/5 2 1 / 2 7 
P3.    7/5 5  4 7 1 
P4.    7/5 3 3  3 3 
P5.    5/4 4 3  2 3 
P6     8/8 8 1 - - - 
P7.    5/3 2 2  2 2 
P8.    5/5 5 3 - - - 
P9.    5/5 5 2 - - - 
P10.  5/3 2 2  1 2 
P11.  5/5 5 3 - 2 - 
P12.  8/4 2 3 1 1 1 
 
Only two out of 9 patients who could use their hands 
brought a caregiver to the laboratory, to learn how to use 
BCI so that they could help at home as required, two of 
these patients lived on their own. All patients had at 
least a secondary school education. Four patients were 
employed, three retired and five stopped working 
after injury. All patients lived in areas within an 
hour drive of the hospital. 
Pain descriptors: Central neuropathic pain was 
present in all patients below the level of injury and all 
patients had pain on their feet and below their knees.  The 
pain was described with standard descriptors of CNP i.e. 
extremely hot (burning) or extremely cold (freezing), 
stinging or as a tightrope (in patients who also had pain 
at the level of injury). All patients first started feeling 
tingling, pleasant warmth and reduction of pain in 
feet. The effect of neurofeedback training 
was assessed using the VNS and also the total body 
area affected by pain. Fig. 4 shows an example of body 
maps affected by pain before and after 3 months 
of training, showing that pain was completely reduced 
in the upper body. 
Patients’ expectations: Prior to demonstrating a 
portable BCI, experimenters asked patients about their 
expectation prompting them to describe the preferred 
weight, and size of the device and the expected usage 
pattern. The majority expected a small and robust device 
that could fit into a handbag. The most frequent 
questions to the experimenter were, how long 
should they wear the headset for? Could they do daily 
activities wearing the headset? And should they use the 
device constantly? The last question indicates that lay 
people, in general do not have a good understanding 
of how BCI works, i.e. that it requires some sort of 
feedback and that it is used intermittently.   
BCI usage pattern: Three patients used the device 
almost daily while most patients used it at least once a 
week. Although they were advised to use the device for 
30 min, P2 used it much shorter while still reporting 
benefits. Most patients used the device in the 
evening when they had more time. Similar to our 
previous study [5], 5 patients who used BCI reported that 
they could bring themselves into the ‘traning’ state 
without using the device, by simply imagining 
doing it. For example, a patient who worked in a call 
center wearing headphones said that he imagined that the 
headphones were the EEG headset and that helped him to 
imagine training and experience less pain. 
Communication with patients: most patients preferred 
SMS or the Internet and two used Skype messenger. We 
offered to all patients video Skype support (the tablet 
computer had a camera) but only one patient used it. The 
laboratory in which patients were recruited was situated 
within the Spinal Injuries  Unit, thus four patients 
preferred coming to the laboratory for a check-up or for 
additional assistance with BCI. This indicates that people 
like having personal contact although electronic 
communication is less time-consuming. 
Perceived usefulness of portable BCI: At the end of 
the first demonstration session patients were asked to 
answer a set of questions shown in Tables  3 and 4. Table 
3 shows perceived usefulness and ease of use of BCI. On 
average, all patients believed that they could understand 
the main purpose of the device and that it would not be 
hard for them and their caregivers to use it. They also 
showed a strong belief towards the potential usefulness 
of the device.  
Attitude towards using a novel technology: Table 4 
showed that all participants had a positive attitude 
towards novel technologies. There was no stigma about 
wearing a gadget on the head in front of family and 
friends. Patients were also asked to choose one or 
more of the following attributes of a new product which 
is most important to them when deciding to buy a device: 
price, aesthetics (looks), size, new features, size of letters 
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and symbols, friends and family already having the 
device, it is novel (only a few people have it), easy 
to relate to something they already have, technical 
support. The most  frequently selected answers were 
“price“ and “new features“, followed by “technical 
support“ and “size“. 
Technical issues  with  EEG headset: 
Three  headsets  frames broke  and two patients asked for 
replacement sponges for the EEG electrodes. The 
most frequent issues were loose electrodes falling out 
from their sockets and difficulty achieving good 
electrode-skin contact. Occasionally slipping 
of the headset was reported due to loosening of the frame 
(after prolonged use) or due to long hair. This was 
resolved by wrapping an elastic band around the headset. 
Technical issues with the custom made software: 
Patients mostly complained of the small size of 
a warning message at the end of the baseline EEG 
recording. Some patients initially forgot to complete to 
pain diary to allow them to start training or log out. A 
major problem was that there was no electronic evidence 
of neurofeedback performance, which could be 
compared from one day to another. 
Other issues affecting the study: The main issue 
affecting the use of BCI was a change of daily routine, 
caused by e.g. unrelated health problems, travels, 
pressure sores which required bed rest, moving 
home and a change of caregiver. Due to the headset 
design, it was inevitable that the location of electrode 
varies from one session to another, possibly influencing 
its performance. Another factor influencing the study 
was a negative opinion of a trusted authority such as a 
general practice doctor (“ We do not really know what 
the device is doing”).  
 
 
DISCUSSION 
 
This feasibility study shows that lay people with a 
mixed social background are capable of using BCI 
technology on their own or with the help of their 
caregivers. Although there are published studies on SCI 
patients views of BCI technology, this is the first study 
in which SCI people actually used BCI on their own.  
Kubler et al. [12] suggested a model of user centered 
design with three main parameters: efficiency, 
effectiveness and satisfaction. In the context of this 
study, effectiveness could be expressed as a reduction of 
pain, efficiency as the number of sessions required to 
learn neurofeedback and time to setup the system. 
Although we did not use validated questionnaires for 
patient satisfaction as suggested in [12] we believe that 
custom made questionnaires (Tables 3 and 4) and semi-
structured interviews cover the areas such as usefulness, 
expected functionality, usage pattern and patient‘s 
appearance while using a device.    
Table 3: Perceived usefulness and the ease of use of a 
portable BCI. Question 3 contains two statements, but it 
was assumed that all people who attended the training 
were interested in having a device. 
Questions Range Average 
1.In your opinion, how 
easy is it to understand 
the main purpose of the 
EEG-tablet system? 
1 very easy 
10 very hard 
2.1±0.7 
2. How easy do you feel 
that it is to use this 
device on a daily basis? 
1 very hard 
10 very easy 
8.0±1.7 
3. I would like to have 
this device but I am not 
sure if  my caregiver 
and I would understand 
how to use it 
1 very false 
10 very true 
1.0±0.0 
4. Please rate how 
much you feel 
convinced that the 
device might help 
reducing your pain? 
1 not at all 
10 very much 
convinced 
7.9±0.7 
 
Table 4: Attitude towards using a novel technology. 
Questions Range Average 
1. Please rate how you 
would feel if other 
people would see you 
wearing the device at 
home 
1 very 
embarrassed 
10 very 
amused 
8.7±1.7 
2. Please rate how you 
would feel if other 
people would know that 
you are using the device 
at home 
1 very 
embarrassed 
10 very 
amused 
8.3±2.2 
3. Please rate your 
attitude towards using a 
novel technology (e.g. 
computers, phones, 
other gadgets)  
1 extreme 
avoidance 
10 extreme 
excitement 
8.4±1.0 
From patients‘ perspective,the largest problem was to 
ensure that the training electrode was always close to C4 
location because the headset was not designed to be used 
over the central area. 
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Another problem was that the initial measurement of 
the impedance was the only check of signal quality 
because patients were not familiar with the morphology  
of EEG and could not check the raw EEG signal. A post-
hoc analysis of EEG signals recorded during 
neurofeedback, indicated that most of the time patients 
were getting an EEG signal of a reasonable quality. 
 
While we did not have a control group, from the initial 
set of 12 patients we selected for home based 
BCI study, only people who, based on our previous 
experience,  had additional self-reported sensations 
(tingling, pleasant warmth) accompanying the reduction 
in pain. About two-thirds of patients in this study 
experienced a reduction of pain. Neurofeedback is a 
technique which requires training and some people who 
did not experience a reduction of pain did not learn how 
to control their brainwaves within 4 training 
sessions.  We showed that people who used BCI at home 
achieved a larger reduction in pain with a prolonged use 
[5].  
While for a patient, self-manged therapy is essential to 
have highly motivated participants, it was possible that 
placebo effect to some extent contributed to the reduction 
in pain because of patients’ high expectation of the 
BCI.   However, the main aim of this study was to test if 
an average adult with no previous knowledge of BCI, 
who may possibly need the assistance 
of a caregiver, could use BCI at home. We believe that 
this study provides some useful information for future 
developers of consumer EEG headsets.  
 
 
 
CONCLUSIONS 
 
The study demonstrates the feasibility of home-based 
patient and caregiver managed BCI therapy for CNP. 
The results of this study should encourage other 
researchers to take BCI from labs and hospitals to 
patients’ homes and should inform the developers of  
wearable consumer BCI devices 
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